FDA approves Mylan's generic Zofran

06/25/2007 | Forbes

Mylan Laboratories won FDA approval of its generic version of GlaxoSmithKline's anti-nausea drug Zofran, prescribed for cancer patients in chemotherapy. Mylan said it plans to begin shipping its product immediately.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
In house Compliance Officer
Pompano Beach, FL
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC